STAT
June 26, 2018
By Adam Feuerstein

Dr. Andrew Lassman, chief of neuro-oncology at NewYork-Presbyterian/Columbia University Irving Medical Center, is more skeptical after reviewing the results at STAT’s request. Lassman was not involved in the study. “I encourage any research in this area that could yield better outcomes, particularly because existing treatments for glioblastoma are so ineffective for patients,” he said. “This [poliovirus] therapy may turn out to be great, but the data are not there yet to conclude that this is the best approach to take.” [read more]

Also covered by: Scientific American